|
KMID : 0918520160160030148
|
|
Journal of the Korean Society of Inherited Metabolic Disease
2016 Volume.16 No. 3 p.148 ~ p.154
|
|
|
The Ornithine Transcarbamylase (OTC) Deficiency Identified by a Novel Mutation
|
|
Song A-Ri
Lee Ki-Wuk
Yang A-Ram
Kim Jin-Sup
Park Hyung-Doo
Cho Sung-Yoon
Jin Dong-Kyu
|
|
|
Abstract
|
|
|
A urea cycle disorder is a condition caused by a defect of the enzymes in the urea cycle, and deficiency
of ornithine transcarbamylase (OTC), which converts carbamoyl phosphate and ornithine into citrulline, is the most common type of the disorder. OTC deficiency induces the accumulation of precursors of urea, ammonia, and glutamine, leading to neurological symptoms including hypotonia, respiratory failure, seizure, lethargy, and coma and sometimes to death. Because OTC deficiency is inherited in an Xlinked manner, typical symptoms such as vomiting, poor feeding, and lethargy appear mainly in male neonates. We recently had a case that presented with neonatal onset lethargy, vomiting, and apnea in a 4-day-old boy. He was diagnosed with OTC deficiency by biochemical phenotype, including hyperammonemia and an increased orotic acid level in the urine. Genetic analysis of the OTC gene showed a novel mutation c.780_781insCAGGCAGTGT (p.Ile261Glnfs*35). He was treated for hyperammonemia using continuous venovenous hemofiltration (CVVH) at 118 hours after birth. After 4 days of CVVH, his consciousness and blood ammonia concentration were normalized, and he was discharged at the age of 53 days. At around 12 months of age, bilateral femur fractures and osteomyelitis occurred in this patient. Two months after the fracture, he died of septic shock, insulin-resistant hyperglycemia, and multi-organ failure.
|
|
|
KEYWORD
|
|
|
Ornithine transcarbamylase deficiency, Neonate, Hemofiltration, Hyperglycemia
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|